Reducing Hereditary Cancer Act

Hozzl · 2025-08-20T08:05:21Z

Explore the details of House Bill 4752 Reducing Hereditary Cancer Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

8/20/2025, 8:05 AM

Summary of Bill HR 4752

The bill, titled H.R. 4752, introduced in the 119th Congress on July 23, 2025, aims to amend title XVIII of the Social Security Act to offer hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history indicating hereditary cancer risk. The bill also proposes coverage for specific cancer screenings and preventive surgeries to mitigate the risk for individuals with an inherited mutation associated with a high likelihood of developing a preventable cancer.

Congressional Summary of HR 4752

Reducing Hereditary Cancer Act

This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 4752

Bill HR 4752 is currently in the status of Bill Introduced since July 23, 2025. Bill HR 4752 was introduced during Congress 119 and was introduced to the House on July 23, 2025. Bill HR 4752's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of July 23, 2025

Bipartisan Support of Bill HR 4752

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 4752

Primary Policy Focus

Alternate Title(s) of Bill HR 4752

To amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer.

Comments

Elowyn Finch

365

3 months ago

I can't believe this new bill is gonna mess with my healthcare. It's like they don't care about us regular folks at all. Why should I have to pay for something that might not even help me? This is just another way for them to control us and take away our freedom. I'm not gonna stand for it! #NotMyBill

Brittany Heller

472

3 months ago

This bill is great, it's gonna help so many people. Did you know it covers genetic testing?

Kaisen Wilkinson

478

3 months ago

I can't believe they are pushing this through without considering the consequences. It's ridiculous how they think this will actually help anyone. #HR4752 is a disaster waiting to happen.